HealthPrep on MSN10mon
Causes And Risk Factors Linked To Avascular Necrosis
Radiation therapy, which patients receive for cancer and other conditions, has been shown to cause avascular necrosis in some ...
Nature23d
Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces apoptosis in various tumor cells in vitro, but its physiological role in tumor surveillance remains unknown. Here ...
The Pharma Letter11h
New Phase II data confirm promise of Imunon’s IMMN-001
New Jersey, USA-based Imunon announced new translational data from the Phase II OVATION 2 Study of IMNN-001, an ...
rheumatologyadvisor20d
Long-Term TNFi Use Does Not Increase Overall Cancer Risk in Psoriasis
Long-term TNFi use in patients with psoriasis was not associated with a higher risk of cancer, including lymphoma, prostate cancer, and breast cancer.
BioWorld3d
Kairos presents next-generation GITR agonist
Glucocorticoid-induced tumor necrosis factor receptor (GITR) and its ligand, GITRL, are involved in immune response ...
healthandpharma1d
IMNN-001: New DNA-Based Immunotherapy Promises to Improve Survival in Ovarian Cancer
IMUNON announced that its new DNA-based immunotherapy for advanced ovarian cancer has shown encouraging results in the ...
Anixa Biosciences Announces Approval of Protocol Amendment for Ovarian Cancer CAR-T Clinical Trial
Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer today announced that it, along with its partner Moffitt ...